| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_RP11-192P3.5_0000400 | Intron-Intron | chr10:31658254-31658480 | chr10:31369325-31369551 | 227 nt | 0.3833 |
| hsa_RP11-192P3.5_0000500 | Intron-Intron | chr10:31658254-31659095 | chr10:31369325-31370166 | 842 nt | 0.3432 |
| hsa_RP11-192P3.5_0000600 | Intron-Intron | chr10:31668922-31669080 | chr10:31379993-31380151 | 159 nt | 0.3396 |
| hsa_RP11-192P3.5_0000700 | Intron-Intron | chr10:31674538-31674709 | chr10:31385609-31385780 | 172 nt | 0.5233 |
| hsa_RP11-192P3.5_0000800 | Intron-Intron | chr10:31677487-31682608 | chr10:31388558-31393679 | 250 nt | 0.2560 |
| hsa_RP11-192P3.5_0000900 | Intron-Intron | chr10:31679923-31680469 | chr10:31390994-31391540 | 547 nt | 0.4022 |
| hsa_RP11-192P3.5_0001000 | Intron-Intron | chr10:31682312-31682591 | chr10:31393383-31393662 | 280 nt | 0.2464 |
| hsa_ZEB1_0000300 | Intergenic-Exon | chr10:31597364-31644121 | chr10:31308435-31355192 | 250 nt | 0.4640 |
| hsa_ZEB1_0000700 | Exon-Exon | chr10:31608181-31750030 | chr10:31319252-31461101 | 106 nt | 0.4057 |
| hsa_ZEB1_0000800 | Exon-Exon | chr10:31608193-31784767 | chr10:31319264-31495838 | 29 nt | 0.6207 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].